Search Options Stock News and Analysis from Schaeffer's

Vaxcyte's Drug Update Pushes 2 Biotech Stocks Lower

https://www.schaeffersresearch.com/content/news/2024/09/03/vaxcytes-drug-update-pushes-2-biotech-stocks-lower

9/3/2024 2:10 PM

Vaxcyte Inc (NASDAQ:PCVX) stock is surging today, after the biotechnology company announced positive study results for its drug designed to prevent invasive pneumococcal disease in adults aged 50 or o...

Options Traders Blast 2 Pharma Socks After Earnings

https://www.schaeffersresearch.com/content/news/2024/07/30/options-traders-blast-2-pharma-socks-after-earnings

7/30/2024 10:12 AM

Pharmaceutical giants Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) today reported second-quarter results. While the former beat top- and bottom-line estimates thanks in part to cancer drug K...

Mixed Inflation Readings Highlight Rocky Week

https://www.schaeffersresearch.com/content/news/2024/04/12/mixed-inflation-readings-highlight-rocky-week

4/12/2024 2:12 PM

It was a rocky week for the Dow Jones Industrial Average (DJI), which was on track for its fifth-straight loss on Friday, and its longest losing streak since June. The blue-chip benchmark was also ...

Pfizer Stock Rises on Upbeat RSV Vaccine Trial Data

https://www.schaeffersresearch.com/content/news/2024/04/09/pfizer-stock-rises-on-upbeat-rsv-vaccine-trial-data

4/9/2024 10:25 AM

Pfizer Inc (NYSE PFE) stock is up 1.7% at $27.04 at last check, following news a late-stage trial of its respiratory syncytial virus (RSV) vaccine Abrysvo generated an immune response in higher risk...

Pfizer Reports Earnings; Stock Eyes 10th-Straight Monthly Loss

https://www.schaeffersresearch.com/content/news/2024/01/30/pfizer-reports-earnings-stock-eyes-10th-straight-monthly-loss

1/30/2024 11:25 AM

Pfizer Inc (NYSE:PFE) entered the earnings ring before the bell this morning, announcing fourth-quarter earnings of 10 cents per share, which is higher than analysts' anticipated losses of 22 cents. R...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity